InSilico Medicine Cayman TopCo (SEHK: 3696)
Health Care · Life Sciences Tools & Services · HK
HK$49.00
+1.58% today · +103.7% 1Y
InSilico Medicine Cayman TopCo (SEHK: 3696) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $3.60B and employs 333 people.
Over the last twelve months the share price has gained 103.7%, trading between 29.98 and 80.90.
Tweenvest scores InSilico Medicine Cayman TopCo across four factors: quality 50/100, value 46/100. Its strongest factor is quality.
3696 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.60B
- Revenue (TTM)
- $135.09M
- P/E
- —
- EPS
- -0.91
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$80.90
- 52-week low
- HK$29.98
- Avg volume (3M)
- —
- Shares outstanding
- 575.84M
- Employees
- 333
- Next earnings
- —
About InSilico Medicine Cayman TopCo
InSilico Medicine Cayman TopCo engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. The company offers Pharma.AI, an AI-powered drug discovery and development platform offering new target identification, small molecule generation, and clinical outcome prediction services. Its pipeline covers solutions for fibrosis, oncology, immunology, metabolic, anti-pain, and other therapeutic areas. The company is also involved in research and development collaboration, software solutions, business development, new drug discovery, and holding company businesses. The company has a strategic collaboration agreement with Suzhou Ribo Life Science Co., Ltd. for the development of oligonucleotide therapeutics; and strategic collaboration with Human Life Foundation Models, Inc. for the development of foundation models for human longevity science. It operates in Hong Kong, the United States, the United Kingdom, Kingdom of Saudi Arabia, Japan, Denmark, the United Arab Emirates, Korea, Mainland China, Germany, Switzerland, Taiwan, and internationally. The company was founded in 2014 and is based in New Territories, Hong Kong.
- ISIN
- KYG4790P1037
- Founded
- 2014
- Listed since
- Dec 30, 2025
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MGI Tech Co., Ltd.SHSE: 688114 | $4.18B | CN¥67.95 | -5.49% |
| AbCellera Biologics Inc.NasdaqGS: ABCL | $4.07B | $12.90 | +2.83% |
| SCHOTT Pharma AG & Co. KGaAXTRA: 1SXP | $3.96B | €23.75 | +1.06% |
| XtalPi Holdings LimitedSEHK: 2228 | $3.83B | HK$6.99 | -12.08% |
| Siegfried Holding AGSWX: SFZN | $3.56B | CHF66.55 | -1.41% |
| Tecan Group AGSWX: TECN | $3.49B | CHF238.00 | +1.28% |
| Sai Life Sciences LimitedNSEI: SAILIFE | $3.27B | Rs1,487.90 | -3.46% |
| Shanghai Haoyuan Chemexpress Co., Ltd.SHSE: 688131 | $2.97B | CN¥93.16 | -6.34% |
Figures last refreshed Oct 11, 2026.